MEDICAL NEWS TODAY | DAILY NEWS
Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative to Wegovy and injectable GLP-1s for weight loss.
 
MEDICALNEWSTODAY | DAILY NEWS
 
Today’s News
Updated on April 9, 2026 at 8:00 a.m. PST
 
FDA approves Wegovy-like GLP-1 pill, Foundayo, for weight loss
 
FDA approves Wegovy-like GLP-1 pill, Foundayo, for weight loss
READ ON
→
Getting too much or too little sleep may increase dementia risk as much as 28%
 
Getting too much or too little sleep may increase dementia risk as much as 28%
READ ON
→
Heart attack, stroke risk can double from irregular bedtimes, sleeping less than 8 hours
 
Heart attack, stroke risk can double from irregular bedtimes, sleeping less than 8 hours
READ ON
→
 
Read Latest news
 
 
MNT REVIEWS
Best At-Home STD Tests: Reliable and Discreet Options
 
Explore convenient, private STI testing options. Our top picks for comprehensive at-home kits with reliable results.
LEARN MORE
 
Biologics for ulcerative colitis: Your FAQs
MNT RESOURCE
Biologics for ulcerative colitis: Your FAQs
What are biologics for ulcerative colitis? Get answers to common questions about biologics, including how effective they are and the safest options, here.
READ ON  
 
 
NEW PODCAST EPISODE
Insomnia and depression: Why ‘just get more sleep’ doesn’t work
 
Insomnia and depression: Why ‘just get more sleep’ doesn’t work
Hosted by Maria Cohut and Yasemin Nikola Sakay
This episode explores the two-way relationship between sleep and mental health, the science of sleep cycles, sleep supplements, and the role of cognitive behavioral therapy (CBT) in treating insomnia.
LISTEN TO THIS EPISODE
LISTEN ON Spotify   Listen on Apple Podcasts  
 
 
Most popular with MNT readers